Publications

CAR-T

Publications

Follicle-stimulating Hormone Receptor is Expressed by Most Ovarian Cancer Subtypes and is a Safe and Effective Immunotherapeutic Target

Breast Cancer Vaccine

Publications

Targeted Vaccination against Human α-Lactalbumin for Immunotherapy and Primary Immunoprevention of Triple Negative Breast Cancer

Cchek^TM

Posters

Combining the Immunophenotyping of MDSCs and Lymphocytes with Artificial Intelligence (AI) to Predict Early Stage Breast Cancer

Combining the Immunophenotyping of MDSCs and Lymphocytes with Artificial Intelligence (AI) to Predict Early Stage Breast Cancer

Combining Machine Learning (ML) with Flow Cytometry Based Immunophenotyping: a Novel Liquid Biopsy Aid for Identifying the Risk for Prostate Cancer (PCa)

Combining Machine Learning (ML) with Flow Cytometry Based Immunophenotyping: a Novel Liquid Biopsy Aid for Identifying the Risk for Prostate Cancer (PCa)

Latest News & Events

Sep 16, 2019

Anixa Biosciences Congratulates Scientific Advisory Board Member Dr. H. Michael Shepard as a 2019 Lasker Award Honoree

Read More...

Aug 26, 2019

Anixa Biosciences to Present at Two Upcoming Investor Conferences

Read More...

Jul 29, 2019

Anixa Biosciences Announces VA North Texas Health Care System to Join Cchek™ Prostate Cancer Study

Read More...

Cancer Fact: Liver cancer accounts for 3.6% of worldwide cancer incidences.